Indian Price Freeze Tweak Sets Stage For Another Clash?
This article was originally published in Scrip
Executive Summary
India's National Pharmaceutical Pricing Authority (NPPA) appears to have made an unusual clarification aimed at freezing prices of new non-scheduled formulations – drugs which don't figure in the country's national list of essential medicines (NLEM) - setting the stage for another potential clash with industry over the legality of the move.